Transaction · 0001035422-26-000015

CTT PHARMACEUTICAL HOLDINGS, INC.

CTT PHARMACEUTICAL HOLDINGS, INC., CEO, reported an open-market or private purchase at CTT PHARMACEUTICAL HOLDINGS, INC. involving 10100.000000 shares for an estimated $454.50. Reported holdings after the transaction were 9424556.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCEO
CTTHCTT PHARMACEUTICAL HOLDINGS, INC.
Filing timeSep 29
Trade dateSep 22, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded0.11%Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 9,414,456 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

CTTH price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CTTH since 2026-09-29Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001035422-26-000015
CTTH
Transaction date
Sep 22, 2026
Filed Sep 29, 2026, 02:22 PM · 7d delay
Shares
10.1k sh
$0.05 per share
Estimated value
$455
Computed from shares × price
Holdings after
9.42M sh
Direct

Filing warnings

Notes recorded with this filing
2 warnings
amended filingThis transaction comes from an amended Form 4 filing.
delayed filingThe filing was reported 7 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Amended Filing CEO Buy Delayed Filing Director Buy Direct Ownership
+18score
Filing-only score

+18

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended

No footnotes recorded.

Amended filing · 0001035422-26-000015
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CTTH